ArticleAnnals of medicine2025

A 5-week low-dose prednisolone regimen for progressive vitiligo: efficacy and safety in a single-center cohort study.

Yue-Tong Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.